This patent teaches how to mobilize stem cells through administration of beta glucan and various derivatives of it. The use of other immune stimulants and TLR agonists should be evaluated for mobilization in future.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.